Ariel University, Ariel, Israel; Dual Diagnosis Clinic, Lev-Hasharon Medical Center, Pardesiya, Israel.
Pain Center, Sourasky Medical Center, Tel Aviv, Israel.
J Affect Disord. 2018 Aug 1;235:293-302. doi: 10.1016/j.jad.2018.04.058. Epub 2018 Apr 10.
In light of the increased rates of Prescription Opioid (PO) misuse and associated mortality in several developed countries in recent years, efforts have been made to identify populations who may be at increased risk for misuse of POs. Though the association between depression and PO misuse among pain patients is well documented, little is known regarding the effects of severity of depression on rates of misuse. In this study we explored rates of PO misuse among chronic pain patients screening positive for depression according to level of severity.
Participants included chronic pain patients receiving POs (N = 554). All participants were screened for depression using the Patient Health Questionnaire (PHQ-9; cut-off scores of 5, 10, 15, and 20 for mild, moderate, moderate-severe and severe depression, respectively) and for opioid misuse using the Current Opioid Misuse Measure (COMM). Logistic regression analyses controlling for additional sociodemographic and clinical factors were conducted.
Participants who screened positive for depression were at significantly increased odds to screen positive for opioid misuse (Adjusted Odds Ratio (AOR) = 3.63; 95% Confidence Interval (CI) = 1.71-7.7) compared to those without depression. Severity of depression was significantly associated with increased odds for opioid misuse for moderate (AOR = 3.71; 95% CI = 1.01-13.76), moderate-severe (AOR = 6.28; 95% CI = 1.6-24.57) and severe (AOR = 14.66; 95% CI = 3.28-65.52) depression but not among those who screened positive for mild depression (AOR = 1.49; 95% CI = 0.39-5.68).
Cross-sectional study.
Our results highlight the need to properly asses and address level of severity of co-morbid depression among chronic pain patients receiving POs.
近年来,一些发达国家处方类阿片(PO)滥用率和相关死亡率上升,因此人们努力确定可能存在 PO 滥用风险的人群。尽管患有疼痛的患者中抑郁与 PO 滥用之间的关系已得到充分证实,但对于抑郁严重程度对滥用率的影响却知之甚少。在这项研究中,我们根据严重程度,研究了患有慢性疼痛且抑郁筛查阳性的患者中 PO 滥用的发生率。
参与者包括接受 PO 治疗的慢性疼痛患者(N=554)。所有参与者均使用患者健康问卷(PHQ-9)筛查抑郁(抑郁的轻、中、中重度和重度的截断分数分别为 5、10、15 和 20),并使用当前阿片类药物滥用测量表(COMM)筛查阿片类药物滥用。对其他社会人口统计学和临床因素进行控制的逻辑回归分析。
与无抑郁的患者相比,抑郁筛查阳性的患者阿片类药物滥用筛查阳性的几率显著增加(调整后的优势比(AOR)=3.63;95%置信区间(CI)=1.71-7.7)。抑郁严重程度与阿片类药物滥用的几率显著相关,中度抑郁(AOR=3.71;95%CI=1.01-13.76)、中重度抑郁(AOR=6.28;95%CI=1.6-24.57)和重度抑郁(AOR=14.66;95%CI=3.28-65.52),但轻度抑郁患者的几率没有增加(AOR=1.49;95%CI=0.39-5.68)。
横断面研究。
我们的研究结果强调,需要对接受 PO 治疗的慢性疼痛患者中并存的抑郁严重程度进行适当评估和处理。